We first used an Arc mutant model of a hypo-functioning mesofrontal circuit ³⁶ for behavioral, anatomical tracing and neural activity imaging studies. To assess whether genetic disruption of Arc (by knocking-in a GFP reporter cassette ⁵⁰) affects cognitive control of behavior, we examined wild-type and Arc homozygous mutant mice in a Y-maze spatial navigation task. This task takes advantage of the innate spatial navigation ability of mice and does not require extensive pretraining, making it well suited for both developmental and adult testing ^51–53. Wild-type mice explore the three arms of the maze using a memory-based decision-making strategy, preferring to visit a new arm instead of the most recently visited arm (Fig. 1a). The percentage of new arm visits out of the total arm visits is referred to as “alternation percentage”, which is approximately 67% in wild-type mice and significantly above the chance level from random exploration (50%). By contrast, the alternation percentage in Arc mutant mice is significantly reduced towards the chance level (p = 0.001, t-test, t(15) = 3.975, WT: 67.2±2.6%, vs. Arc-/-: 53.4±2.3%, N = 8 and 9 mice, respectively; Fig. 1b). Arc mutant mice showed a similar number of total arm entries as the wild-type mice (Fig. 1c), suggesting that the Arc mutation did not affect overall locomotor activity or motivation level. Taken together, these results suggest that Arc mutant mice have a deficit in memory-guided choice behaviors.

Optimal performance in the Y-maze requires an intact frontal cortex and ventral tegmental area ^54–56. The M2 region of the frontal cortex plays an important role in action planning, generating the earliest neural signals related to upcoming choice during spatial navigation ^{57, 58}. To verify the involvement of the M2 cortex in Y-maze alternation, we expressed the chemogenetic inhibitor DREADD-Gi ⁵⁹ in M2 with an Adeno-Associated Viral (AAV) vector and used Clozapine-N-Oxide (CNO) injection to inhibit M2 neural activity in wild-type mice (Supplementary Fig. 1a). We found that the alternation percentage was significantly reduced in the DREADD-Gi animals compared with control animals (p = 0.017, t-test, t(10)=2.845, Ctrl: 64.6±1.8%, Gi:54.1±3.2%, N=6 for each group, Supplementary Fig. 1b), while other aspects of motor behaviors in this task were not affected (Supplementary Fig. 1c and 1d). These results confirm the involvement of M2 frontal cortical neurons in memory-guided decision-making during the Y-maze task.

Dopaminergic input from the ventral tegmental areas is critical to optimal frontal cortical function in controlling cognitive processes ^22–24. We examined the anatomical structure of the frontal dopaminergic projection to determine if this input was altered in Arc mutant mice. A Tyrosine Hydroxylase (TH), rather than a Dopamine Transporter (DAT), transgenic Cre line was used to efficiently label mesofrontal dopamine neurons, because of the higher expression level of TH over DAT in these neurons ^{60, 61}. Cre-dependent AAV vectors were injected into the VTA of TH-Cre mice to label dopaminergic axons with tdTomato and highlight boutons with synaptophysin-GFP (Fig. 1d and e) ^{46, 62, 63}. Although the dopaminergic axon length in the M2 frontal cortex (normalized by the number of labeled cells in VTA) was not significantly different between Arc mutant and wildtype animals (Fig. 1f), we found a significant reduction in the dopaminergic bouton density in this region in Arc mutant mice compared to wildtype animals (p = 0.034, t-test, t(12)=2.393, WT: 100±5%, Arc -/-:84±5%, N=7 for each group; bouton density normalized by axon length; Fig. 1g). These results suggest that dopaminergic innervations of the M2 frontal cortex are reduced in Arc mutant mice, which agrees with our previous findings of reduced frontal dopamine release and mesofrontal activity in Arc-/- mice ³⁶. Our new results provide further anatomical evidence for a hypofunctional mesofrontal dopamine circuit in these mice.

To determine how M2 neuronal activities during Y-maze performance might be affected by Arc mutation and reduced dopaminergic input, we expressed a genetically encoded calcium indicator GCaMP6 ⁶⁴ in superficial layer (L2/3) M2 neurons and used a head-mounted miniaturized microscope ^{62, 65–67} to image task-related neuronal ensemble activity in adult wild-type and Arc-/- mice (Fig. 2a). The microscope lens was placed above the pial surface rather than inserted into the cortex to avoid damage of M2 neurons, and neuronal activities in superficial cortical layers were imaged (Supplementary Fig. 2a-2c, Supplementary Movie 1). We found that the activity of individual M2 neurons occurred at various positions along the track during Y-maze navigation (Fig. 2b). An increased proportion of neurons showed peak activation when the wild-type animal was near the center of the maze before making an arm entry (Fig. 2c). In contrast, this proportion was significantly reduced in Arc mutant mice compared to wild type animals (p < 0.0001, chi-square test, WT 938 cells from 8 mice, Arc-/- 1338 cells from 7 mice). This effect is not due to a general reduction of neural activity in Arc-/- mice, because there is no difference between wild-type and Arc-/- mice in the average activity of neurons throughout the task period (Supplementary Fig. 2d-f). In addition, there is no correlation between the average activity of neurons with alteration behaviors in Y-maze (Supplementary Fig. 2j). Thus, these results suggest that the coordinated activation of M2 neurons before making a choice is disrupted in Arc mutant mice.

To further examine how exploratory choices may be encoded in the activities of individual M2 neurons, we compared the neuronal activity patterns along the navigation trajectories leading to new arm visits versus old arm visits. Neurons selective for alternation were identified by differential neural activation between alternating and non-alternating paths (Fig. 2d). This analysis showed that the proportion of alternation-selective neurons increased in the wild type mice as the animal approached the maze center, but this increase was blunted in the Arc mutant animals (p < 0.0001, chi-square test, Fig. 2e). These same mutant animals also showed a specific reduction of alternation choices in the Y-maze (p = 0.047, t-test, t(13)=2.196, WT: 67.8 ± 4.4%, N = 8 mice; Arc-/-: 54.5 ± 4.1%, N = 7 mice, Supplementary Fig. 2g-i), replicating the deficit we observed in separate groups of animals that did not carry the miniaturized microscope (Fig. 1b). Together, these results demonstrate that both task-related frontal cortical activity and memory-guided decision behavior are impaired in Arc mutant mice.

Given the hypo-functioning mesofrontal dopaminergic circuit in Arc mutant mice, we next investigated the possibility of developing neurostimulation strategies to restore normal circuit functions. We have previously shown that a brief stimulation of midbrain dopamine cells during adolescence, but not adult, leads to rapid formation of mesofrontal dopaminergic boutons and enhanced mesofrontal circuit activity in wild-type mice ⁴⁶. Here, we chose to test the long-term effect of this adolescent intervention strategy on the frontal circuit and memory-guided decision-making deficits in adult Arc mutant mice.

To stimulate dopamine neuron activity, we expressed chemogenetic activator DREADD-Gq ⁶⁸ in the VTA dopamine cells using a combination of stereotaxically injected Cre-dependent AAV vectors and a TH-Cre transgenic mouse line ⁴⁶ (Fig. 3a, Supplementary Fig. 3a). CNO (1mg/kg) was injected systemically to enhance the activity of DREADD-Gq-expressing dopamine neurons. To control for any potential off-target effect of CNO, another group of TH-Cre mice that expressed AAV-mCherry reporter in dopamine neurons also received CNO injection.

Previous studies have shown that DREADD-Gq induced neural activation reaches its peak approximately 1 hr after CNO injection and returns to baseline approximately 9 hr after injection⁶⁸. Increased VTA dopamine activity is known to enhance frontal cortical activity, which can be measured with calcium indicator GCaMP6 ^{36, 46, 69}. We validated the DREADD-Gq induced enhancement of mesofrontal activity by examining M2 cortical activity with GCaMP6 before and after CNO injection in these mice (Fig. 3a and b, Supplementary Fig. 3b). There was a significant increase in the M2 cortical activity measured 1 hr after the injection of CNO in DREADD-Gq animals, whereas no significant effect occurred in control mCherry animals (DREADD-Gq: 82±17% vs. mCherry Ctrl: 20±14%, p = 0.018, t-test, t(10)=2.814, N=6 for each group; Fig. 3c). In addition, saline injection in DREADD-Gq expressing mice did not alter M2 neural activity, and CNO-induced increase in M2 neural activity was suppressed by D1 antagonist SCH23390 (Supplementary Fig. 3c). These results confirmed CNO-induced activation of the mesofrontal dopaminergic circuit in DREADD-Gq animals.

After the validation of activity enhancement by chemogenetic stimulation of dopamine neurons, we examined if this treatment would have any long-term effect on the circuit deficits in Arc mutant mice. We first tested whether the structural deficits in the mesofrontal dopaminergic circuit would be affected by adolescent dopamine neuron stimulation. DREADD-Gq or mCherry expression was combined with tdTomato and synaptophysin-GFP to label dopaminergic axons and boutons in the Arc mutant animals (Arc-/-;TH-Cre). After three CNO treatments in adolescence (one injection per day for three days in mice 5 weeks of age in their home cages), the mice were kept in their regular home cage until adulthood (8 weeks) for histological assessment (Fig. 3d). Although the mesofrontal dopamine axon length did not show any difference (Fig. 3e), we found a significant increase in dopaminergic bouton density in DREADD-Gq mice compared to control animals (Ctrl:100±4% vs. Gq:120±6%, p = 0.013, t-test, t(18)=2.763, N=10 for each group; Fig. 3f). These results suggest that adolescent dopamine neuron stimulation in Arc mutant mice led to a long-term enhancement of the connection between dopaminergic axons and M2 frontal cortical neurons, thereby ameliorating the structural deficits in these mice.

We next tested whether adolescent dopamine neuron stimulation would also lead to long-term improvement of the functional deficits in the mesofrontal circuit of Arc mutant mice. Our previous work indicated that Arc mutants have reduced frontal cortical response to VTA stimulation ³⁶. Using the same assay in adult mice, we found that the cortical calcium activity in response to VTA electrical stimulation was significantly enhanced in DREADD-Gq mice compared to control mCherry mice after adolescence CNO treatment (Fig. 3g-i). These results suggest that adolescent dopamine neuron stimulation also leads to long-term improvement of the functional deficits in the mesofrontal dopaminergic circuit of Arc mutants.

To further examine whether the uncoordinated frontal neural activity patterns in Arc mutant mice during the Y-maze task would be renormalized by this adolescent dopamine neuron stimulation strategy, we conducted calcium imaging using the head-mounted miniature microscope in these mice (Fig. 4a). We found that the coordinated activation of neurons near the maze center (Fig. 4b) and the proportion of alternation-selective neurons (Fig. 4c) were both significantly enhanced in Arc mutant mice that received the DREADD-Gq activation compared to the mCherry control group (p < 0.0001, chi-square tests, DREADD-Gq 1008 cells from 7 mice, mCherry 1286 cells from 7 mice). In contrast, the average activity of M2 neurons throughout the task period was not affected by adolescent DREADD-Gq stimulation (Supplementary Fig. 4a-c). Strikingly, the DREADD-Gq stimulated animals also showed an enhancement of behavioral alternation (p = 0.010, t-test, t(12)=3.043, Ctrl:56.8±2.8%, Gq:67.6±2.2%, N=7 each group, Fig 4d), reaching a level comparable to that in the wild-type mice (Fig. 1b). Total arm entries were not affected (Fig. 4e), suggesting no alternations in general locomotor activity. These results indicate that adult task-related functional activity in the M2 frontal cortex is restored by adolescent dopamine neuron stimulation in Arc mutant mice.

To further characterize the experimental conditions that are important for the restoration of memory-guided decision-making behavior in Arc mutant mice, we examined several variables including post-stimulation test interval, stimulation duration, and the age of stimulation. First, we replicated the effects of adolescent dopamine neuron stimulation on Y-maze navigation in adulthood in another cohort of Arc mutant mice (p = 0.023, t-test, t(12)=2.598, Ctrl:59.5±2.4%, Gq:68.5±2.5%, N=7 for each group) (Fig. 5a). Furthermore, when tested only one day after the three-day CNO treatment procedure (one injection per day) in adolescence, Arc mutant mice already showed an increased alternation percentage (p = 0.031, t-test, t(20)=2.322, Ctrl:55.8±2.9%, Gq:64.7±2.5%, N=11 for each group) (Fig. 5b), which is comparable to the effect observed one-month after treatment in adult mice (Fig. 5a). These results suggest that the adolescent neurostimulation effect on cognitive behavioral improvement is both fast acting and long lasting.

Second, we also tested a more intense CNO stimulation procedure involving two injections per day for three weeks (5 days per week) starting in adolescence. However, this strong three-week stimulation did not enhance behavioral alternation and appeared to decrease it even further (Fig. 5c). These results indicate that excessive stimulation of dopamine neurons does not lead to functional improvement, consistent with previous studies showing that an optimal level of dopamine is important for normal cognitive function ^22–24.

Third, we found that in adult Arc mutant mice with DREADD-Gq expression, three-day CNO injection did not lead to any effects on Y-maze alternation behavior assayed one-month later (Fig. 5d). These results indicate that adolescent, but not adult, intervention is critical for reversing this behavioral dysfunction, in agreement with the elevated adolescent structural and functional plasticity reported for the mesofrontal circuit ⁴⁶. In addition, because 3 weeks of adolescent CNO treatment or 3 days of adult CNO treatment in DREADD-Gq mice did not lead to any rescue effects, DREADD-Gq expression alone is unlikely to generate any behavior improvement. Taken together, our findings suggest that a brief stimulation of midbrain dopamine neurons in adolescence has a long-lasting effect to reverse the memory-guided decision-making deficits in Arc mutant mice, while not affecting other aspects of motor behaviors in the Y-maze (Supplementary Fig. 5).

To further evaluate the impact of adolescent dopamine neuron stimulation on another frontal cortex-dependent behavioral deficit in Arc mutant mice, we subjected these mice to an amphetamine-induced hyperactivity test, which is considered an animal model for drug-induced psychomotor symptoms ^{36, 70}. Classical neuropharmacological studies have shown that amphetamine-induced locomotor activity is facilitated by dopaminergic input to the nucleus accumbens but inhibited by dopaminergic input to the frontal cortex ^71–73. Consistent with a hypoactive frontal dopamine input, Arc mutant mice showed hyper-reactivity to amphetamine compared to the wild-type mice (Figure Supplementary Fig. 6a) as reported before ³⁶.

However, we found that adolescent stimulation of VTA dopamine neurons through DREADD-Gq did not reduce the hyper-reactivity to amphetamine in adult Arc mutant mice (Supplementary Fig. 6b). Dopamine neurons in the VTA include separate neuronal populations that project to the frontal cortex and the nucleus accumbens, respectively ^{18, 61}. Our results suggest that adolescent stimulation of both populations of VTA neurons in mesofrontal and mesoaccumbens pathways, which have opposing effects on amphetamine-induced locomotor activity, result in no net change in this behavioral phenotype at adulthood.

Subsequently, we tested whether targeted stimulation of dopaminergic axons projecting to the frontal cortex would be a better strategy to reinstate memory-guided decision-making in the Y-maze task and prevent amphetamine hyper-reactivity in Arc mutant mice. Although CNO in principle could be injected directly into the frontal cortex to stimulate DREADD-Gq labeled dopaminergic axons, we found in preliminary experiments that repeated injections (three times) in adolescent brain led to tissue deformation and damage. Therefore, we turned to a less invasive optogenetic method to enhance the activity of labeled axons using Stabilized Step Function Opsins (SSFOs), which can increase neural excitability over a 30-min time scale in response to a two-sec pulse of light ⁷⁴.

To validate the effect of SSFO-based stimulation, we expressed Cre-dependent SSFO in the midbrain dopamine neurons and stimulated their axonal projections in the M2 frontal cortex with blue light through a cranial window (Fig. 6a; Supplementary Fig. 6c-d). We monitored M2 neural activity using calcium reporter GCaMP6 before and 30 min after light activation. Similar to the DREADD-Gq mediated activity changes in the mesofrontal circuit, frontal cortical activity was increased after light activation compared to before in SSFO animals, and this increase was significantly higher than the control EGFP animals that were also exposed to the light (p = 0.001, t-test, t(8)=5.135, Ctrl: 7.5±3.1%, SSFO: 46.7±6.9%, N=5 each group, Fig. 6b-c, Supplementary Fig. 6e). These results indicate that light stimulation of SSFO-labeled frontal dopamine axons can enhance the activity in the mesofrontal circuit.

To determine whether adolescent stimulation of mesofrontal dopamine axons would be sufficient to reinstate memory-guided decision-making in Arc mutant mice, we stimulated SSFO-labeled dopamine axons in the frontal cortex once per day for three days in adolescence (Fig. 6d). When tested either one day after light stimulation or one month after in adulthood, SSFO-labeled mice showed a significant increase in the Y-maze alternation percentage compared to control EGFP animals (Fig. 6e, 1 day after, p = 0.028, t-test, t(15)=2.440, Ctrl:58.4±1.4%, SSFO:66.5±3.2%; Fig. 6g, adulthood, p = 0.015, t-test, t(15)=2.748, Ctrl: 55.5±2.5%, SSFO: 66.7±3.3%; N = 9 for Ctrl, N = 8 for SSFO). On the other hand, total arm entries were not affected (Fig. 6f and 6h). These results suggest that similar to VTA dopamine neuron stimulation, projection-specific stimulation of dopaminergic axons in the frontal cortex is sufficient to restore memory-guided decision-making in Arc mutant animals.

Moreover, SSFO-mediated frontal dopamine axon stimulation in adolescence also significantly reduced the hyper-reactivity to amphetamine in adult Arc mutant mice (*p = 0.037, F(1,14)=5.3, Two-way ANOVA, N = 8 each, Fig 6i). Thus, adolescent stimulation of dopaminergic projections in the frontal cortex provides an effective strategy for reversing frontal dysfunctions in both memory-guided decision-making and psychostimulant reactivity.

Finally, we sought to determine if this adolescent neurostimulation strategy would be applicable to another genetic model with a hypoactive mesofrontal circuit. Previous studies showed that knocking-down DISC1 or overexpressing a dominant negative DISC1 reduced mesofrontal dopaminergic innervation, dopamine release and cognitive dysfunction ^{34, 35}. Using a DISC1 mouse model that contains a knocked-in mutation identified from a subset of human patients ^{33, 75}, we first examined whether mesofrontal activity is also impaired in this model by imaging the calcium activity of M2 frontal cortex with two-photon microscopy in response to VTA stimulation (Fig. 7a). Our results showed a reduction of VTA-induced frontal cortical activity in DISC1 mutants compared to wildtype animals (10 pulse F(1,10)=16.5, *p=0.002, Two-way ANOVA, N=6 mice per group, Fig. 7b), indicating a mesofrontal hypofunction in this DISC1 mutant line consistent with other DISC1 models ^{34, 35}.

To further determine if our DISC1 mutants have deficits in memory-guided decision-making, we conducted the Y-maze test and found reduced alternation in the DISC1 mutants compared to the wildtype animals (p = 0.044, t-test, t(18)=2.171, WT:66.8±2.6%, DISC1+/-:58.9±2.5%, N=10 for each group; Fig. 7c). Thus, similar to Arc mutant mice, DISC1 mutant mice also exhibit a hypofunctional mesofrontal circuit and impaired cognitive function.

We then tested whether the same adolescent neurostimulation strategy used in the Arc mutant mice would also reverse the cognitive deficits in DISC1 mutants. Remarkably, we found that the alternation percentage in adult DISC1 animals was significantly increased after adolescent neurostimulation (p = 0.012, t-test, t(9)=3.139, Ctrl:60.7±2.4%, N=5, Gq:69.3±1.5% N=6, Fig. 7d), reaching a level comparable to the wild-type mice. Other aspects of motor behaviors in the Y-maze were not affected (Supplementary Fig. 7). Taken together, these results suggest that adolescent dopamine neuron stimulation is effective for long-term cognitive improvement in two different genetic models of mesofrontal hypofunction.

In this study, we have demonstrated a powerful role of adolescent dopaminergic input in inducing long-lasting circuit reorganization to reverse genetic deficits in frontal cortex function. Previous studies of dopamine function have focused on its transient neuromodulatory actions on neural dynamics or involvement in reinforcement learning ^76–79. Here, by examining the effect of dopamine neuron stimulation over a developmental time scale, we have identified both fast acting and persistent effect of adolescent dopamine neuron activity at neuroanatomical, neurophysiological, and behavioral levels. The cognitive dysfunction present in adolescent mutant mice is readily reversed one-day after neurostimulation and the restored performance level is maintained even one-month later at adulthood. Interestingly, the behavioral improvement afforded by dopamine neuron stimulation is observed when the intervention was introduced transiently during the adolescence period, but not adulthood, suggesting a sensitive and limited time window for plasticity-inducing therapeutic manipulations within mesofrontal dopamine circuits. These results may also stimulate future research to identify the molecular and cellular mechanisms controlling the adolescent plasticity window and explore the possibility and therapeutic potential of reopening plasticity in adulthood ^{46, 80–82}.

Our examination across different mechanistic levels suggests a coherent picture in which increased dopamine neuron activity in adolescence leads to enhanced frontal dopaminergic innervation and cortical response to dopamine. Previous electrophysiological studies have suggested that dopamine can act on five different receptors expressed in both excitatory and inhibitory neurons to increase signal-to-noise ratio and temporal synchrony in network electrophysiological activity ^{25, 78, 79, 83–86}. The neural activity deficit in Arc-/- mice is manifested in the task-coordinated neuronal activation at the decision-making point, but not in the average activity throughout the task. The uncoordinated neural activation pattern in Arc-/- mice may contribute to increased noise and decreased signal for decision-making, consistent with the hypodopaminergic cortical state in Arc-/- mice and the computational role of dopamine in enhancing the signal-to-noise ratio of neuronal ensemble activities^{25, 78, 79, 83–86}. After adolescent dopamine neuron stimulation, frontal dopaminergic innervation and cortical response to dopamine are enhanced, which help to restore task-coordinated neuronal activation in adult animals. As coordinated neuronal activity in frontal cortex is implicated in cognitive functions ^{87, 88}, the restoration of this activity may underlie the rescue of the cognitive behavioral deficit in Arc mutant mice. It is interesting to note that dopaminergic signaling can impact both excitatory and inhibitory neurons in the frontal cortex, and the local GABAergic inhibitory network undergoes major functional remodeling during adolescence⁸¹. The microcircuit mechanisms underlying adolescent dopamine neuron stimulation induced neuronal coordination changes will be an exciting direction for future research.

Our studies have shown that the mesofrontal dopamine circuit is a common target disrupted by mutations in Arc and DISC1, both implicated in neuropsychiatric disorders ^30–33. Arc and DISC1 have different protein interaction partners and function in distinct molecular pathways. Arc is best understood for its role in regulating the trafficking of excitatory neurotransmitter receptors at synapses, whereas DISC1 has been shown to act as a scaffold protein to interact with multiple cytoskeletal proteins and synaptic molecules ^89–92. Dopamine-related deficits have been reported in multiple Arc and DISC1 mutant lines or direct knockdown of these molecules ^{34–36, 93–95}, but the exact molecular mechanisms underlying these deficits and the varying severity in different models remain to be elucidated in future studies. Considering the widely reported roles of Arc and DISC1 in regulating activity-dependent synaptic plasticity^{96, 97}, mutations in these genes may compromise activity-dependent maturation of the mesofrontal dopaminergic circuit. In the two mouse lines we tested, both Arc and DISC1 mutations lead to a hypoactive mesofrontal circuit and deficits in memory-guided decision-making behaviors. Our study demonstrates that the cognitive behavioral phenotypes arising from distinct genetic origins can be effectively rescued by the same neurostimulation strategy targeting a convergent mesofrontal circuit phenotype during a critical adolescent window.

Our work reveals a specific circuit target for long-lasting restoration of cognitive control functions. Dopamine neurons projecting to the frontal cortex are located in the VTA but are distinct from those projecting to the nucleus accumbens ^{18, 61}. Our initial chemogenetic neuromodulation strategies targeted most of the dopamine neurons in the VTA. While changes in the mesofrontal dopamine circuit were clearly induced, we cannot rule out other potential changes in the brain that might be also induced by such a targeting strategy and result in the lack of net effect related to amphetamine reactivity. The more refined optogenetic (SSFO) neurostimulation method allowed us to specifically target the dopaminergic axons projecting to the frontal cortex. Enhancing their activity transiently in adolescence is sufficient to not only restore memory-guided decision making in the Y-maze task but also prevent hyper-reactivity to amphetamine. Thus, the mesofrontal dopaminergic circuit may provide an important therapeutic target to restore both cognitive control functions and prevent psychomotor symptoms. While this study focused on the M2 region of the frontal cortex because it generates the earliest neural signals related to upcoming choice during spatial navigation and is optically most accessible^{57, 58}, the medial prefrontal regions (anterior cingulate, prelimbic and infralimbic) beneath M2 also receive dense dopaminergic innervation and can act in concert with M2 in decision making⁹⁸. It will be interesting for future research to further dissect the effects of dopaminergic activation in specific frontal subregions.

Achieving fast-acting and enduring improvement of cognitive function while avoiding psychotic exacerbation has been a long-standing challenge for neuroscience and psychiatric research ^{2, 6, 7, 99}. Our results suggest that adolescent frontal dopaminergic projections may provide an effective target. Developmentally guided and circuit-based intervention strategies that use clinical brain stimulation, local pharmacological application, or behavioral training methods ^{37, 39, 86, 100} to engage the adolescent mesofrontal dopamine circuit may offer new routes to treat cognitive and behavior control disorders.

Arc-/- ⁵⁰, DISC1+/- ⁷⁵, and hemizygote TH-Cre transgenic ¹⁰¹ mice in the C57BL/6 strain were used in this study. Arc-/-;TH-Cre and DISC1+/-;TH-Cre lines were generated by in-house breeding. Mice were normally housed in groups of 2-5 animals. Estrous cycles are known to affect frontal dopamine activity ^{102, 103} and the experiments in this study are limited to male mice of appropriate genotypes. It will be important for future studies to examine female mice at various estrous stages. Litter mates were randomly assigned into control or experimental groups. Behavioral tests were run blinded to the experimental conditions. Experimental protocols were approved by the National Institute of Mental Health Animal Care and Use Committee and the University Committee on Animal Resources (UCAR) at the University of Rochester Medical Center.